Sachdev Amit
SEC CIK 1406338 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals | EVP, Chief Patient Off | 66.5K | — | $37.69M | 38 | 2021-11-15 | 2026-07-21 |
Most active insiders at VRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEIDEN JEFFREY M | Executive COB, Dir | — | $60.94M |
| 2 | Sachdev Amit | EVP Chief Patient, Ext Af Off | — | $28.38M |
| 3 | Kewalramani Reshma | CEO, Pres, Dir | — | $19.74M |
| 4 | Bozic Carmen | EVP, CMO | — | $11.31M |
| 5 | WAGNER CHARLES F JR | EVP, CO, FO | — | $10.78M |
| 6 | Tatsis Ourania | EVP, Chief Reg, Quality Off | — | $6.51M |
| 7 | McKechnie Duncan | EVP, Chief Commercial Off | — | $5.66M |
| 8 | Biller Jonathan | EVP, CLO | — | $4.08M |
| 9 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | — | $3.60M |
| 10 | Bunnage Mark E. | EVP, CSO | — | $3.00M |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-23 16:13 | 2026-07-21 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +8,251 | 66.5K | +14% | $0 | |
| 2026-02-26 | 2026-02-24 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $485.11 | -1,518 | 57.4K | -3% | -$736.4K | |
| 2026-02-26 | 2026-02-25 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $486.35 | -1,846 | 55.6K | -3% | -$897.8K | |
| DM | 2026-02-23 | 2026-02-19 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale+OE | $468.83 | -58.6K | 63.2K | -48% | -$27.48M |
| DM | 2026-02-23 | 2026-02-19 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | M - OptEx | $172.06 | +48.5K | 117.5K | +70% | +$8.35M |
| 2026-02-19 | 2026-02-17 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +5,789 | 71.2K | +9% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $483.75 | -2,140 | 69.0K | -3% | -$1.04M | |
| 2026-02-18 | 2026-02-13 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $487.76 | -3,548 | 65.4K | -5% | -$1.73M | |
| 2026-02-12 | 2026-02-10 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $468.41 | -2,057 | 68.9K | -3% | -$963.5K | |
| M | 2026-01-26 | 2026-01-22 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +11.7K | 71.0K | +20% | $0 |
| 2025-02-28 | 2025-02-26 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $479.61 | -3,703 | 68.5K | -5% | -$1.78M | |
| 2025-02-26 | 2025-02-24 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $483.28 | -2,470 | 72.2K | -3% | -$1.19M | |
| 2025-02-19 | 2025-02-14 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $463.46 | -2,139 | 74.7K | -3% | -$991.3K | |
| 2025-02-14 | 2025-02-12 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +6,211 | 76.8K | +9% | $0 | |
| 2025-02-12 | 2025-02-10 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $467.98 | -2,056 | 70.6K | -3% | -$962.2K | |
| M | 2025-02-06 | 2025-02-04 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +15.3K | 65.5K | +31% | $0 |
| I | 2024-06-07 | 2024-06-05 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | G - Gift | $0.00 | -4,600 | 0 | -100% | $0 |
| 2024-05-17 | 2024-05-15 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $430.93 | -32 | 55.3K | -0.1% | -$13.8K | |
| 2024-02-27 | 2024-02-23 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $431.79 | -2,469 | 58.3K | -4% | -$1.07M | |
| 2024-02-27 | 2024-02-26 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $425.70 | -3,004 | 55.3K | -5% | -$1.28M | |
| 2024-02-23 | 2024-02-21 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $421.77 | -3,191 | 60.8K | -5% | -$1.35M | |
| 2024-02-21 | 2024-02-20 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $420.79 | -4,254 | 64.0K | -6% | -$1.79M | |
| M | 2024-02-21 | 2024-02-16+ | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $422.54 | -6,121 | 70.9K | -8% | -$2.59M |
| 2024-02-13 | 2024-02-12 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $420.24 | -3,222 | 74.4K | -4% | -$1.35M | |
| 2024-02-13 | 2024-02-09 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | F - Tax | $422.74 | -2,022 | 77.6K | -3% | -$854.8K | |
| M | 2024-02-08 | 2024-02-06+ | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | A - Grant | $0.00 | +20.8K | 64.6K | +47% | $0 |
| 2023-11-17 | 2023-11-15 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $369.92 | -35 | 58.8K | -0.1% | -$12.9K | |
| 2023-08-14 | 2023-08-10 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | S - Sale | $350.00 | -10.0K | 58.8K | -15% | -$3.51M | |
| 2023-02-28 | 2023-02-24 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | F - Tax | $289.12 | -2,468 | 66.5K | -4% | -$713.5K | |
| 2023-02-22 | 2023-02-17 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | F - Tax | $292.85 | -3,498 | 69.0K | -5% | -$1.02M | |
| M | 2023-02-14 | 2023-02-10+ | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | F - Tax | $296.85 | -7,268 | 72.5K | -9% | -$2.16M |
| I | 2023-02-03 | 2022-05-17 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | G - Gift | $0.00 | -1,672 | 11.1K | -13% | $0 |
| M | 2023-02-03 | 2023-02-01 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | A - Grant | $0.00 | +26.4K | 79.8K | +49% | $0 |
| 2022-02-28 | 2022-02-24 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | F - Tax | $227.86 | -7,368 | 48.2K | -13% | -$1.68M | |
| 2022-02-22 | 2022-02-17 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | F - Tax | $232.51 | -3,497 | 55.6K | -6% | -$813.1K | |
| 2022-02-14 | 2022-02-10 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | F - Tax | $237.74 | -2,491 | 59.1K | -4% | -$592.2K | |
| M | 2022-02-03 | 2022-02-01 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | A - Grant | $0.00 | +29.6K | 41.7K | +245% | $0 |
| M | 2021-11-16 | 2021-11-15 | VRTX | Vertex Pharmaceuticals | Sachdev Amit | EVP, Chief Patient Off | S - Sale | $187.19 | -51 | 31.9K | -0.2% | -$9,547 |
Purchase Sale Sale after option exercise All abbreviations